← Leaderboards
Victor J Navarro
Yale University
$5,633,586
Attributed
$6,432,599
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $561.8K · FY2006–22$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,432,599 · 3
By mechanism
U01$6,432,599 · 2
M01$0 · 1
Top collaborators
- Rajender Kuchikulla Reddy8 shared
Most similar at Yale University
Same institution · by research overlap
- Sonia Caprio$32,446,602
- Margaret A. Riley$3,887,364
Others in their field
Top investigators on “Injury”
- Polly Chang · Sri International$119,352,977
- Marco Pahor · Wake Forest University Health Sciences$82,312,292
- Kerry J Kelly · New York City Fire Department$81,924,266
- Asrar B. Malik · University Of Illinois At Chicago$81,164,529
- Peter Scott Heeger · Case Western Reserve University$76,259,223
- Jacqueline Moline · Icahn School Of Medicine At Mount Sinai$75,762,106
Research focus
InjuryUnited States National Institutes Of HealthPharmaceutical PreparationsResourcesProspectiveLiverTissuesSamplingFundingBaseDelawareReportingCase-BasedRepositoryInternetLiver InjuryInsightScientistGrantCollaborationsEtiologyDetectionProviderAcute
Grant awards (27)
The Drug Induced Liver Injury Network (DILIN): Focus on Herbal and DietarySupplements$390,000
U01 · FY2022 · DK · contact PI
The Drug Induced Liver Injury Network (DILIN): Focus on Herbal and DietarySupplements$400,000
U01 · FY2021 · DK · contact PI
The Drug Induced Liver Injury Network (DILIN): Focus on Herbal and Dietary Supplements$395,000
U01 · FY2020 · DK · contact PI
The Drug Induced Liver Injury Network (DILIN): Focus on Herbal and Dietary Supplements$298,291
U01 · FY2019 · DK · contact PI
The Drug Induced Liver Injury Network (DILIN): Focus on Herbal and Dietary Supplements$317,500
U01 · FY2018 · DK · contact PI
Prospective Surveillance Drug and HDS-Induced Liver Injury$434,839
U01 · FY2017 · DK · contact PI
Prospective Surveillance Drug and HDS-Induced Liver Injury$491,046
U01 · FY2016 · DK · contact PI
Prospective Surveillance Drug and HDS-Induced Liver Injury$343,064
U01 · FY2015 · DK · contact PI
Chemical Analysis of Herbal and Dietary Supplements (HDS); Identification of Candidate Hepatotoxins$110,596
U01 · FY2015 · DK · contact PI
DILIN Supplement for HDS Repository$31,154
U01 · FY2015 · DK · contact PI
Prospective Surveillance Drug and HDS-Induced Liver Injury$342,316
U01 · FY2014 · DK · contact PI
Prospective Surveillance Drug and HDS-Induced Liver Injury$343,766
U01 · FY2013 · DK · contact PI
Continuation and Expansion of the Drug Induced Liver Injury Network(PHILLY-DILIN)$168,995
U01 · FY2012 · DK · contact PI
Continuation and Expansion of the Drug Induced Liver Injury Network(PHILLY-DILIN)$73,144
U01 · FY2012 · DK · contact PI
Continuation and Expansion of the Drug Induced Liver Injury Network(PHILLY-DILIN)$250,885
U01 · FY2011 · DK · contact PI
Continuation and Expansion of the Drug Induced Liver Injury Network(PHILLY-DILIN)$231,680
U01 · FY2010 · DK · contact PI
Continuation and Expansion of the Drug Induced Liver Injury Network(PHILLY-DILIN)$206,466
U01 · FY2010 · DK · contact PI
Silymarin for the Treatment of Nonalcoholic Steatohepatitis$82,402
U01 · FY2010 · AT · contact PI
Continuation and Expansion of the Drug Induced Liver Injury Network(PHILLY-DILIN)$253,723
U01 · FY2009 · DK · contact PI
Continuation and Expansion of the Drug Induced Liver Injury Network(PHILLY-DILIN)$178,063
U01 · FY2009 · DK · contact PI
Silymarin for the Treatment of Nonalcoholic Steatohepatitis$50,883
U01 · FY2009 · AT · contact PI
Silymarin for the Treatment of Nonalcoholic Steatohepatitis$326,741
U01 · FY2008 · AT · contact PI
Continuation and Expansion of the Drug Induced Liver Injury Network(PHILLY-DILIN)$235,070
U01 · FY2008 · DK · contact PI
Silymarin for the Treatment of Nonalcoholic Steatohepatitis$318,410
U01 · FY2007 · AT · contact PI
Silymarin for the Treatment of Nonalcoholic Steatohepatitis$158,565
U01 · FY2006 · AT · contact PI
INTERFERON ALPHA PLUS RIBAVIRIN FOR TREATMENT OF REFRACTORY HEPATITIS C$0
M01 · FY2001 · RR
INTERFERON ALPHA PLUS RIBAVIRIN FOR TREATMENT OF REFRACTORY HEPATITIS C$0
M01 · FY2000 · RR